Tag: tumor marker testing market demand

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Veterinary Cardiology Market Size Outlook: How Quickly Will Revenue Expand Through 2030?

The veterinary cardiology market has demonstrated substantial growth in recent years. Its value is projected to expand from $3.1 billion in 2025 to $3.38 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.1%. This historical expansion can be attributed to several factors including a higher incidence of congenital heart defects in companion animals, increased understanding of pet health requirements, an expanding presence of veterinary hospitals and clinics, innovations in diagnostic imaging techniques, and the adoption of conventional pharmaceuticals for treating cardiac conditions.

The veterinary cardiology market size is expected to experience significant growth in the coming years. It is projected to expand to $4.73 billion by 2030, showing a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period is attributed to the growing acceptance of telemedicine in veterinary cardiology, increased pet insurance penetration, the creation of AI-driven diagnostic instruments, a heightened focus on proactive and individualized cardiac care, and the rising number of companion animals in urban areas. Significant developments anticipated during this period include telecardiology and remote heart monitoring, less invasive cardiac interventions, custom treatment approaches for companion animals, sophisticated cardiac imaging methods, and the use of nutraceuticals for preventative heart health.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=20681&type=smp&name=Veterinary%20Cardiology%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Cardiology Market Demand Drivers Opening New Revenue Streams

The increasing instances of heart conditions in pets and livestock are anticipated to stimulate the expansion of the veterinary cardiology market in the future. These conditions involve medical issues that impact the heart’s structure and performance, leading to impaired blood circulation, reduced cardiac efficiency, and potential wider health complications. The surge in heart diseases among pets and livestock is influenced by elements such as longer lifespans, obesity, inadequate nutrition, genetic predispositions, and a lack of consistent veterinary attention. Additionally, environmental pressures and changes in living environments can contribute to the prevalence of cardiovascular issues in these animals. Veterinary cardiology offers diagnosis, treatment, and management for heart diseases in pets and livestock through specialized care, advanced imaging, and innovative procedures like minimally invasive surgeries, aiming to improve cardiac health and quality of life. For instance, in March 2024, according to the American Veterinary Medical Association, a US-based not-for-profit organization, Myxomatous mitral valve degeneration (MMVD) stands as the most common heart disease in dogs in North America, representing 75% of all canine cardiac conditions. It is documented that 85% of small dogs aged 13 years show indicators of a myxomatous mitral valve lesion, although the mere presence of a lesion does not always signify clinical importance. In cases involving MMVD, the estimated rate of cardiac-related deaths in dogs falls between 40% and 70%. Therefore, the growing number of heart disease cases in pets and livestock will propel the growth of the veterinary cardiology market.

Veterinary Cardiology Market Segment Outlook: Which Categories Are Growing Fastest?

The veterinary cardiology market covered in this report is segmented –

1) By Product: Pharmaceuticals, Diagnostics

2) By Indication: Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Other Indications

3) By Animal Type: Companion Animals, Production Animals

4) By End-User: Veterinary Hospitals, Clinics, Other End Users

Subsegments:

1) By Pharmaceuticals: Antihypertensives, Diuretics, Antiarrhythmic Drugs, Beta Blockers, ACE Inhibitors, Calcium Channel Blockers, Positive Inotropes, Nutraceuticals For Cardiac Health

2) By Diagnostics: Electrocardiograms (ECG), Echocardiography Devices, Holter Monitors, Blood Pressure Monitors, Cardiac Biomarker Tests, Thoracic Radiography, Ultrasound Devices, Telemedicine Solutions for Cardiac Monitoring

Veterinary Cardiology Market Trends Powering Strategic Industry Growth

Major companies in the veterinary cardiology market are developing technological advancements, including transcatheter edge-to-edge mitral valve repair (TEER), to improve the treatment of heart conditions in animals, enhance surgical results, and provide minimally invasive alternatives for better patient recuperation and quality of life. Transcatheter edge-to-edge mitral valve repair (TEER) is a less intrusive heart procedure aimed at correcting mitral valve leakage by employing a clamp to improve valve function and reduce strain on the heart. For example, in February 2023, Willows Veterinary Centre, a UK-based veterinary referral facility, introduced an innovative heart treatment for dogs to manage myxomatous mitral valve disease (MMVD), which is the most prevalent heart ailment in dogs. This treatment is now considered a viable alternative to surgical repair in human patients, with early clinical outcomes in dogs demonstrating significant potential. The procedure is performed under general anesthesia via a minor incision in the chest wall. A needle is inserted at the heart’s apex, guided precisely by continuous X-rays and transesophageal ultrasound. This method facilitates the accurate positioning of a V-clamp across the mitral valve to minimize leakage.

Veterinary Cardiology Market Competitive Landscape: Which Companies Lead The Industry?

Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Santé Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet

View The Full Veterinary Cardiology Market Report:

https://thebusinessresearchcompany.com/report/veterinary-cardiology-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Cardiology Market Regional Breakdown: Where Is Demand Concentrated?

North America was the largest region in the veterinary cardiology market in 2025. The regions covered in the veterinary cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

#Veterinary Cardiology Market Size Outlook: How Quickly Will Revenue Expand Through 2030?#_x000D_

The veterinary cardiology market has demonstrated substantial growth in recent years. Its value is projected to expand from $3.1 billion in 2025 to $3.38 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.1%. This historical expansion can be attributed to several factors including a higher incidence of congenital heart defects in companion animals, increased understanding of pet health requirements, an expanding presence of veterinary hospitals and clinics, innovations in diagnostic imaging techniques, and the adoption of conventional pharmaceuticals for treating cardiac conditions._x000D_

_x000D_

The veterinary cardiology market size is expected to experience significant growth in the coming years. It is projected to expand to $4.73 billion by 2030, showing a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period is attributed to the growing acceptance of telemedicine in veterinary cardiology, increased pet insurance penetration, the creation of AI-driven diagnostic instruments, a heightened focus on proactive and individualized cardiac care, and the rising number of companion animals in urban areas. Significant developments anticipated during this period include telecardiology and remote heart monitoring, less invasive cardiac interventions, custom treatment approaches for companion animals, sophisticated cardiac imaging methods, and the use of nutraceuticals for preventative heart health._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=20681&type=smp&name=Veterinary%20Cardiology%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Veterinary Cardiology Market Demand Drivers Opening New Revenue Streams#_x000D_

The increasing instances of heart conditions in pets and livestock are anticipated to stimulate the expansion of the veterinary cardiology market in the future. These conditions involve medical issues that impact the heart’s structure and performance, leading to impaired blood circulation, reduced cardiac efficiency, and potential wider health complications. The surge in heart diseases among pets and livestock is influenced by elements such as longer lifespans, obesity, inadequate nutrition, genetic predispositions, and a lack of consistent veterinary attention. Additionally, environmental pressures and changes in living environments can contribute to the prevalence of cardiovascular issues in these animals. Veterinary cardiology offers diagnosis, treatment, and management for heart diseases in pets and livestock through specialized care, advanced imaging, and innovative procedures like minimally invasive surgeries, aiming to improve cardiac health and quality of life. For instance, in March 2024, according to the American Veterinary Medical Association, a US-based not-for-profit organization, Myxomatous mitral valve degeneration (MMVD) stands as the most common heart disease in dogs in North America, representing 75% of all canine cardiac conditions. It is documented that 85% of small dogs aged 13 years show indicators of a myxomatous mitral valve lesion, although the mere presence of a lesion does not always signify clinical importance. In cases involving MMVD, the estimated rate of cardiac-related deaths in dogs falls between 40% and 70%. Therefore, the growing number of heart disease cases in pets and livestock will propel the growth of the veterinary cardiology market._x000D_

_x000D_

#Veterinary Cardiology Market Segment Outlook: Which Categories Are Growing Fastest?#_x000D_

The veterinary cardiology market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Pharmaceuticals, Diagnostics_x000D_

2) By Indication: Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Other Indications_x000D_

3) By Animal Type: Companion Animals, Production Animals_x000D_

4) By End-User: Veterinary Hospitals, Clinics, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Pharmaceuticals: Antihypertensives, Diuretics, Antiarrhythmic Drugs, Beta Blockers, ACE Inhibitors, Calcium Channel Blockers, Positive Inotropes, Nutraceuticals For Cardiac Health _x000D_

2) By Diagnostics: Electrocardiograms (ECG), Echocardiography Devices, Holter Monitors, Blood Pressure Monitors, Cardiac Biomarker Tests, Thoracic Radiography, Ultrasound Devices, Telemedicine Solutions for Cardiac Monitoring _x000D_

_x000D_

#Veterinary Cardiology Market Trends Powering Strategic Industry Growth#_x000D_

Major companies in the veterinary cardiology market are developing technological advancements, including transcatheter edge-to-edge mitral valve repair (TEER), to improve the treatment of heart conditions in animals, enhance surgical results, and provide minimally invasive alternatives for better patient recuperation and quality of life. Transcatheter edge-to-edge mitral valve repair (TEER) is a less intrusive heart procedure aimed at correcting mitral valve leakage by employing a clamp to improve valve function and reduce strain on the heart. For example, in February 2023, Willows Veterinary Centre, a UK-based veterinary referral facility, introduced an innovative heart treatment for dogs to manage myxomatous mitral valve disease (MMVD), which is the most prevalent heart ailment in dogs. This treatment is now considered a viable alternative to surgical repair in human patients, with early clinical outcomes in dogs demonstrating significant potential. The procedure is performed under general anesthesia via a minor incision in the chest wall. A needle is inserted at the heart’s apex, guided precisely by continuous X-rays and transesophageal ultrasound. This method facilitates the accurate positioning of a V-clamp across the mitral valve to minimize leakage._x000D_

_x000D_

#Veterinary Cardiology Market Competitive Landscape: Which Companies Lead The Industry?#_x000D_

Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Santé Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet _x000D_

_x000D_

#View The Full Veterinary Cardiology Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/veterinary-cardiology-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Veterinary Cardiology Market Regional Breakdown: Where Is Demand Concentrated?#_x000D_

North America was the largest region in the veterinary cardiology market in 2025. The regions covered in the veterinary cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Veterinary Cardiology Market During 2026–2030?

The veterinary cardiology market size has experienced robust expansion in recent years. It is projected to grow from $3.1 billion in 2025 to $3.38 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.1%. The growth observed in the historical period can be attributed to several factors including an increased prevalence of congenital heart defects in pets, a rising awareness regarding pet healthcare, a growing number of veterinary hospitals and clinics, advancements in diagnostic imaging technologies, and the adoption of conventional pharmaceuticals for cardiac diseases.

The veterinary cardiology market is anticipated to show substantial expansion over the coming years. By 2030, its valuation is set to reach $4.73 billion, driven by a compound annual growth rate (CAGR) of 8.7%. This projected increase during the forecast period stems from several factors, including the growing adoption of telemedicine in veterinary cardiology, an increase in pet insurance coverage, the emergence of AI-enabled diagnostic instruments, a heightened emphasis on preventive and tailored cardiac care, and the expanding companion animal population within urban areas. Key developments anticipated for this period involve telecardiology & remote cardiac monitoring, minimally invasive cardiac procedures, personalized treatment plans for companion animals, advanced cardiac imaging techniques, and nutraceuticals & preventive cardiac care.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20681&type=smp

Which Growth Factors Are Strengthening The Veterinary Cardiology Market Landscape?

The rising cases of heart diseases in pets and livestock are expected to propel the growth of the veterinary cardiology market going forward. Heart diseases in pets and livestock refer to medical conditions that affect the heart’s structure and function, leading to impaired blood circulation, reduced cardiac efficiency, and potential complications in overall health. The rising cases of heart diseases in pets and livestock are driven by factors such as increased lifespan, obesity, poor diet, genetic predispositions, and a lack of regular veterinary care. Additionally, environmental stressors and changes in living conditions can contribute to the prevalence of cardiovascular conditions in these animals. Veterinary cardiology helps diagnose, treat, and manage heart diseases in pets and livestock through specialized care, advanced imaging, and innovative procedures like minimally invasive surgeries to improve heart health and quality of life. For instance, in March 2024, according to the American Veterinary Medical Association, a US-based not-for-profit organization, Myxomatous mitral valve degeneration (MMVD) is the most prevalent heart disease in dogs in North America, making up 75% of all canine cardiac conditions. It is reported that 85% of small dogs aged 13 years show signs of a myxomatous mitral valve lesion, although the presence of a lesion does not necessarily have clinical significance. In cases of MMVD, the estimated rate of cardiac-related deaths in dogs is between 40% and 70%. Therefore, the rising cases of heart diseases in pets and livestock will drive the growth of the veterinary cardiology market.

How Is The Veterinary Cardiology Market Distributed Across Key Segments?

The veterinary cardiology market covered in this report is segmented –

1) By Product: Pharmaceuticals, Diagnostics

2) By Indication: Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Other Indications

3) By Animal Type: Companion Animals, Production Animals

4) By End-User: Veterinary Hospitals, Clinics, Other End Users

Subsegments:

1) By Pharmaceuticals: Antihypertensives, Diuretics, Antiarrhythmic Drugs, Beta Blockers, ACE Inhibitors, Calcium Channel Blockers, Positive Inotropes, Nutraceuticals For Cardiac Health

2) By Diagnostics: Electrocardiograms (ECG), Echocardiography Devices, Holter Monitors, Blood Pressure Monitors, Cardiac Biomarker Tests, Thoracic Radiography, Ultrasound Devices, Telemedicine Solutions for Cardiac Monitoring

Which Trends Are Affecting The Veterinary Cardiology Market Framework?

Major companies operating in the veterinary cardiology market are developing technological advancements, such as transcatheter edge-to-edge mitral valve repair (TEER), to improve the treatment of heart diseases in animals, enhance surgical outcomes, and offer minimally invasive alternatives for better patient recovery and quality of life. Transcatheter edge-to-edge mitral valve repair (TEER) is a less invasive heart procedure designed to fix mitral valve leakage by using a clamp to improve valve function and reduce heart strain. For instance, in February 2023, Willows Veterinary Centre, a UK-based veterinary referral center, launched a groundbreaking heart treatment for dogs to treat myxomatous mitral valve disease (MMVD), which is the most common heart condition in dogs. It is now regarded as a viable alternative to surgical repair in human patients, with early clinical results in dogs showing great promise. The procedure is conducted under general anesthesia through a minor incision in the chest wall. A needle is inserted at the heart’s apex, with precise guidance provided by continuous X-rays and transesophageal ultrasound. This method facilitates the accurate placement of a V-clamp across the mitral valve to minimize leakage.

Who Are The Businesses Driving Activity In The Veterinary Cardiology Market?

North America was the largest region in the veterinary cardiology market in 2025. The regions covered in the veterinary cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Veterinary Cardiology Market Report:

https://www.thebusinessresearchcompany.com/report/veterinary-cardiology-global-market-report

What Is The Largest Regional Market In The Veterinary Cardiology Market?

North America was the largest region in the veterinary cardiology market in 2025. The regions covered in the veterinary cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Veterinary Cardiology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=20681&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Aripiprazole Market Projected To Become By 2030 Based On Its 2026 Valuation?

The veterinary cardiology market size has experienced strong growth in recent years. It is projected to expand from $3.1 billion in 2025 to $3.38 billion in 2026, at a compound annual growth rate (CAGR) of 9.1%. This historical growth can be linked to an increased prevalence of congenital heart defects in pets, rising awareness about pet healthcare, a growing number of veterinary hospitals and clinics, advancements in diagnostic imaging technologies, and the adoption of conventional pharmaceuticals for cardiac diseases.

The veterinary cardiology market is projected to witness significant growth in the coming years, expanding to $4.73 billion in 2030 with a compound annual growth rate (CAGR) of 8.7%. This anticipated growth during the forecast period is driven by factors such as the increasing adoption of telemedicine in veterinary cardiology, a rise in pet insurance coverage, the development of AI-enabled diagnostic tools, an enhanced focus on preventive and personalized cardiac care, and the expanding companion animal population in urban regions. Key trends for this period encompass telecardiology and remote cardiac monitoring, the use of minimally invasive cardiac procedures, personalized treatment plans for companion animals, advanced cardiac imaging techniques, and the integration of nutraceuticals for preventive cardiac care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20681&type=smp

What Primary Drivers Are Shaping The Development Of The Aripiprazole Market?

The expanding occurrences of heart diseases in pets and livestock are projected to boost the growth of the veterinary cardiology market moving forward. These conditions in animals refer to medical issues affecting the heart’s structure and function, leading to impaired blood circulation, reduced cardiac efficiency, and potential broader health complications. The surge in heart disease cases in pets and livestock stems from factors like extended lifespans, obesity, poor dietary habits, genetic predispositions, and insufficient regular veterinary care. Moreover, environmental stressors and alterations in living conditions can contribute to the prevalence of cardiovascular conditions in these animals. Veterinary cardiology aids in the diagnosis, treatment, and management of heart diseases in pets and livestock by offering specialized care, advanced imaging, and innovative procedures such as minimally invasive surgeries to enhance heart health and overall quality of life. For example, in March 2024, the American Veterinary Medical Association, a US-based not-for-profit organization, reported that Myxomatous mitral valve degeneration (MMVD) is the most common heart disease in dogs in North America, constituting 75% of all canine cardiac conditions. It is noted that 85% of small dogs aged 13 years exhibit signs of a myxomatous mitral valve lesion, although this presence does not always carry clinical significance. For dogs with MMVD, the estimated rate of cardiac-related deaths falls between 40% and 70%. Thus, the growing incidence of heart diseases in pets and livestock will propel the expansion of the veterinary cardiology market.

What Segment Groups Are Identified Within The Aripiprazole Market?

The veterinary cardiology market covered in this report is segmented –

1) By Product: Pharmaceuticals, Diagnostics

2) By Indication: Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Other Indications

3) By Animal Type: Companion Animals, Production Animals

4) By End-User: Veterinary Hospitals, Clinics, Other End Users

Subsegments:

1) By Pharmaceuticals: Antihypertensives, Diuretics, Antiarrhythmic Drugs, Beta Blockers, ACE Inhibitors, Calcium Channel Blockers, Positive Inotropes, Nutraceuticals For Cardiac Health

2) By Diagnostics: Electrocardiograms (ECG), Echocardiography Devices, Holter Monitors, Blood Pressure Monitors, Cardiac Biomarker Tests, Thoracic Radiography, Ultrasound Devices, Telemedicine Solutions for Cardiac Monitoring

What Trends Are Advancing Progress In The Veterinary Cardiology Market?

Major entities within the veterinary cardiology market are advancing technologically, introducing innovations like transcatheter edge-to-edge mitral valve repair (TEER) to enhance the treatment of cardiac conditions in animals, improve surgical outcomes, and provide minimally invasive alternatives for better patient recovery and overall quality of life. Transcatheter edge-to-edge mitral valve repair (TEER) is a less intrusive cardiac procedure engineered to remedy mitral valve leakage by utilizing a clamp to optimize valve function and alleviate heart strain. As an illustration, in February 2023, Willows Veterinary Centre, a UK-based veterinary referral facility, initiated a pioneering heart therapy for dogs aimed at treating myxomatous mitral valve disease (MMVD), which stands as the most common heart ailment in canines. This treatment is now considered a viable substitute for surgical interventions in human patients, with early clinical data from dogs showing considerable promise. The process is carried out under general anesthesia through a small incision in the chest wall. A needle is inserted at the heart’s apex, with exact direction ensured by continuous X-rays and transesophageal ultrasound. This approach allows for the accurate placement of a V-clamp across the mitral valve to effectively reduce leakage.

Which Companies Hold Significant Positions In The Aripiprazole Market?

Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Santé Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet

Read the full veterinary cardiology market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-cardiology-global-market-report

How Does The Aripiprazole Market Perform Across Major Global Regions?

North America was the largest region in the veterinary cardiology market in 2025. The regions covered in the veterinary cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Aripiprazole Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20681&type=smp

Browse Through More Reports Similar to the Global Veterinary Cardiology Market 2026, By The Business Research Company

Veterinary Pain Management Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

Veterinary Reference Laboratory Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-reference-laboratory-global-market-report

Veterinary Stereotactic Radiosurgery System Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-stereotactic-radiosurgery-system-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the hand hygiene stations market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Veterinary Cardiology Market show for the 2026–2030 period?

The veterinary cardiology market has seen substantial growth in recent years. It is anticipated to expand from $3.1 billion in 2025 to $3.38 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.1%. This historical expansion can be primarily attributed to the increased prevalence of congenital heart defects in pets, rising awareness about pet healthcare, a growing number of veterinary hospitals and clinics, advancements in diagnostic imaging technologies, and the adoption of conventional pharmaceuticals for cardiac diseases.

The veterinary cardiology market is projected to experience substantial expansion over the coming years, with its size anticipated to reach $4.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. This expected growth during the forecast period is primarily driven by factors such as the increasing adoption of telemedicine within veterinary cardiology, an expansion in pet insurance coverage, the development of AI-enabled diagnostic tools, a heightened focus on preventive and personalized cardiac care, and the growing population of companion animals in urban areas. Significant trends identified for the forecast period include the rise of telecardiology and remote cardiac monitoring, the prevalence of minimally invasive cardiac procedures, the implementation of personalized treatment plans for companion animals, the use of advanced cardiac imaging techniques, and the integration of nutraceuticals and preventive cardiac care.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20681&type=smp

What Drivers Are Shaping The Development Of The Veterinary Cardiology Market?

An anticipated surge in heart disease occurrences among domestic animals and farm animals is projected to fuel the expansion of the veterinary cardiology market moving ahead. These cardiac conditions in pets and livestock involve health issues impacting the heart’s anatomy and performance, resulting in poor blood flow, diminished heart effectiveness, and potential broader health problems. The escalating frequency of heart conditions in pets and livestock is attributable to various elements including longer life expectancies, excessive weight, inadequate nutrition, inherited tendencies, and insufficient routine veterinary attention. Furthermore, environmental pressures and alterations in their habitats may also play a role in the widespread occurrence of cardiovascular ailments among these animals. Specialized veterinary cardiac care aids in the diagnosis, treatment, and management of heart ailments in pets and livestock, utilizing advanced imaging techniques and novel interventions such as minimally invasive surgical operations to enhance cardiac well-being and overall quality of life. As an illustration, in March 2024, the American Veterinary Medical Association, a non-profit entity based in the U.S., reported that Myxomatous mitral valve degeneration (MMVD) represents the most common heart ailment observed in dogs across North America, accounting for 75% of all canine cardiac issues. Reports indicate that 85% of small dog breeds at 13 years of age exhibit indications of a myxomatous mitral valve lesion, although the mere existence of such a lesion does not always carry clinical importance. For dogs afflicted with MMVD, the projected mortality rate due to cardiac causes ranges from 40% to 70%. Consequently, the escalating incidence of heart ailments in pets and livestock is set to propel the expansion of the veterinary cardiology market.

Which Segments Are Contributing To The Growth Of The Veterinary Cardiology Market?

The veterinary cardiology market covered in this report is segmented –

1) By Product: Pharmaceuticals, Diagnostics

2) By Indication: Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Other Indications

3) By Animal Type: Companion Animals, Production Animals

4) By End-User: Veterinary Hospitals, Clinics, Other End Users

Subsegments:

1) By Pharmaceuticals: Antihypertensives, Diuretics, Antiarrhythmic Drugs, Beta Blockers, ACE Inhibitors, Calcium Channel Blockers, Positive Inotropes, Nutraceuticals For Cardiac Health

2) By Diagnostics: Electrocardiograms (ECG), Echocardiography Devices, Holter Monitors, Blood Pressure Monitors, Cardiac Biomarker Tests, Thoracic Radiography, Ultrasound Devices, Telemedicine Solutions for Cardiac Monitoring

Which Market Trends Are Opening Growth Opportunities In The Veterinary Cardiology Market?

Major companies active in the veterinary cardiology market are advancing technology, including transcatheter edge-to-edge mitral valve repair (TEER), to enhance the treatment of heart conditions in animals. These innovations aim to improve surgical outcomes and provide less invasive options for better patient recovery and quality of life. Transcatheter edge-to-edge mitral valve repair (TEER) itself is a minimally invasive cardiac procedure developed to correct mitral valve leakage by utilizing a clamp to optimize valve function and lessen strain on the heart. As an illustration, in February 2023, Willows Veterinary Centre, a veterinary referral center located in the UK, unveiled a novel heart treatment for dogs suffering from myxomatous mitral valve disease (MMVD), the most prevalent heart ailment in canines. This treatment is now recognized as a viable substitute for surgical intervention in human patients, with early clinical findings in dogs showing great promise. The procedure is performed under general anesthesia through a small incision in the chest wall, where a needle is inserted at the heart’s apex. Continuous X-ray and transesophageal ultrasound provide precise guidance for the accurate placement of a V-clamp across the mitral valve, thereby minimizing leakage.

Who Are The Major Companies Operating In The Veterinary Cardiology Market?

Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Santé Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-cardiology-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Veterinary Cardiology Market?

North America was the largest region in the veterinary cardiology market in 2025. The regions covered in the veterinary cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary Cardiology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20681&type=smp

Browse Through More Reports Similar to the Global Veterinary Cardiology Market 2026, By The Business Research Company

Veterinary Pain Management Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

Veterinary Reference Laboratory Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-reference-laboratory-global-market-report

Veterinary Stereotactic Radiosurgery System Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-stereotactic-radiosurgery-system-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Discover trends, market shifts, and competitive outlooks for the veterinary cardiology industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Is the Current and Projected Market Size of the Veterinary Cardiology Market Through 2034?#_x000D_

The market size of veterinary cardiology has seen substantial expansion in the past few years, with projections of growth from $2.84 billion in 2024 to $3.1 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.1%. The growth during that historical period has been due to several factors, including higher rates of pet ownership, increased understanding of pet health, escalating occurrences of heart-related disorders in animals, the growth of specialized veterinary clinics, and the growing accessibility and affordability of insurance for pets._x000D_

_x000D_

The market for veterinary cardiology is projected to witness significant expansion in the coming years. By 2029, it is estimated to reach $4.35 billion, with a compound annual growth rate (CAGR) of 8.8%. This anticipated rise during the forecast period can be linked to increased funding in veterinary cardiology studies, the development of telemedicine for distancing consultations, an escalating pet adoption rate, growing customer demand for specialized veterinary services, and enhanced accessibility of progressive veterinary cardiology educational initiatives. Major future trends feature cloud security strategies, consolidated collaborative platforms, amplified emphasis on data privacy and adherence, expedited transition to multi-cloud settings, and the creation of more adaptable and scalable cloud infrastructure solutions._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=20681&type=smp_x000D_

_x000D_

#What Are the Major Market Drivers Behind the Rising Adoption of Veterinary Cardiology Market?#_x000D_

The increasing instances of cardiac issues in animals and livestock are anticipated to fuel the expansion of the veterinary cardiology market in the future. Cardiac conditions in pets and livestock are health issues that disrupt the heart’s structure and function, causing inadequate blood flow, decreased cardiac productivity, and potential risks to overall wellbeing. The boost in heart illnesses in pets and livestock can be credited to various factors like extended lifespan, obesity, unbalanced diet, hereditary tendencies, and insufficient routine veterinary maintenance. Moreover, environmental pressures and shifts in living arrangements can add to the commonness of heart-related diseases in these creatures. Veterinary cardiology plays a pivotal role in diagnosing, treating, and managing heart diseases in domestic and farm animals by offering specialized care, advanced imaging, and innovative techniques such as minimally invasive surgeries to enhance cardiac health and quality of life. For example, data from the American Veterinary Medical Association in March 2024, a non-profit organization based in the US, revealed that Myxomatous mitral valve degeneration (MMVD) accounts for 75% of all dog heart diseases in North America, making it the most common canine cardiac condition. It’s worth noting that 85% of small dogs aged 13 years show signs of a myxomatous mitral valve lesion, despite not all lesions holding clinical significance. With MMVD, the estimated heart-related mortality rate ranges from 40% to 70%. Thus, the increase in instances of heart diseases in pets and livestock is set to propel the growth of the veterinary cardiology market._x000D_

_x000D_

#Which Key Market Segments Comprise the Veterinary Cardiology Market and Drive Its Revenue Growth?#_x000D_

The veterinary cardiology market covered in this report is segmented –_x000D_

_x000D_

1) By Product: Pharmaceuticals, Diagnostics_x000D_

2) By Indication: Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Other Indications_x000D_

3) By Animal Type: Companion Animals, Production Animals_x000D_

4) By End-User: Veterinary Hospitals, Clinics, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Pharmaceuticals: Antihypertensives, Diuretics, Antiarrhythmic Drugs, Beta Blockers, ACE Inhibitors, Calcium Channel Blockers, Positive Inotropes, Nutraceuticals For Cardiac Health_x000D_

2) By Diagnostics: Electrocardiograms (ECG), Echocardiography Devices, Holter Monitors, Blood Pressure Monitors, Cardiac Biomarker Tests, Thoracic Radiography, Ultrasound Devices, Telemedicine Solutions for Cardiac Monitoring_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=20681&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Veterinary Cardiology Market Expansion Across the Globe?#_x000D_

North America was the largest region in the veterinary cardiology market in 2024. The regions covered in the veterinary cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Which Technological Trends Are Reshaping the Veterinary Cardiology Industry Dynamics?#_x000D_

Leading businesses in the veterinary cardiology market are working on technological advancements like transcatheter edge-to-edge mitral valve repair (TEER) to improve treatment for animals suffering from heart diseases, to enhance surgery results, and provide less invasive options for improved patient recovery and life quality. TEER is a less invasive procedure aimed to rectify mitral valve leaks by using a clamp to enhance the valve function and decrease heart stress. For example, in February 2023, Willows Veterinary Centre, based in the UK, introduced an innovative heart treatment for dogs to manage myxomatous mitral valve disease (MMVD), the prevalent heart disease among dogs. This intervention is now considered as a potential alternative to surgical repair in humans, with the initial clinical outcomes in dogs demonstrating substantial potential. The procedure is performed under complete anesthesia via a minor chest wall incision. A needle is inserted at the apex of the heart, with continued X-rays and transesophageal ultrasound providing exact guidance. This technique enables the precise positioning of a V-clamp across the mitral valve to reduce leakage._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/veterinary-cardiology-global-market-report_x000D_

_x000D_

#How Is the Veterinary Cardiology Market Conceptually Defined?#_x000D_

Veterinary cardiology is the branch of veterinary medicine focused on identifying and managing animal heart diseases, ranging from routine examinations to advanced treatments. It enhances the quality of life for pets by providing specialized diagnosis and treatment for heart conditions, leading to improved health outcomes and extended lifespans._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20681_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model